aim microfluidic chips Search Results


90
AIM Biotech microfluidic chips
Microfluidic Chips, supplied by AIM Biotech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/aim+microfluidic+chips/pm32622118-89-1-6?v=AIM+Biotech
Average 90 stars, based on 1 article reviews
microfluidic chips - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
AIM Biotech identx 3 microfluidic device
Identx 3 Microfluidic Device, supplied by AIM Biotech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/aim+microfluidic+chips/pm39836089__am4c18845_si_001-2-6-4?v=AIM+Biotech
Average 90 stars, based on 1 article reviews
identx 3 microfluidic device - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
AIM Biotech microfluidic chips with one gel channel and two media channels
Microfluidic Chips With One Gel Channel And Two Media Channels, supplied by AIM Biotech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/aim+microfluidic+chips/pmc08452600-154-10-12?v=AIM+Biotech
Average 90 stars, based on 1 article reviews
microfluidic chips with one gel channel and two media channels - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
AIM Biotech microfluidic chip assays
Microfluidic Chip Assays, supplied by AIM Biotech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/aim+microfluidic+chips/pm38508081-363-0-7?v=AIM+Biotech
Average 90 stars, based on 1 article reviews
microfluidic chip assays - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
AIM Biotech aim microfluidic chips
Characterization of TC arrest under flow in the MVNs. (a) Schematic diagram of the <t>microfluidic</t> device used to perfuse MVNs under a constant pressure difference Δ p and cells being carried by luminal flow into (A) narrow channels and (B) impacting the endothelium at bifurcations or (C) large vessels (partially realized with Biorender.com). (b) Speed of inert beads carried by luminal flow driven by different pressure differences ( n = 50 beads tracked in 3 devices, average and standard deviation shown) and arrest efficiency of TCs ( n = 4 devices, average and standard deviation shown) as a function of the pressure difference. (c) Confocal image of two arrest mechanisms showing MDA-MB-231 cells within MVNs arrested by (1) physical trapping and (2) adhesion. The scale bar is 200 µm. (d) Bead speed through the MVNs (n as above, the error bars indicate the standard deviation) and vessel diameter as a function of specific GCX component removal (the error bars indicate the standard deviation between the averages of n = 3 devices, 3 regions of interest each). (e) Arrest efficiency of TCs as a function of GCX enzymatic treatment of the MVNs alone, TCs alone, or both MVNs and TCs ( n = 4 devices). (f) Cumulative percentage of TCs either physically trapped in small vessels or adhered to large vessels in the MVNs ( n > 40 cells). Statistical significance assessed for all data portrayed by 138 student’s t-test, p < 0.05 *, p < 0.01 **, p < 0.0001 ****.
Aim Microfluidic Chips, supplied by AIM Biotech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/aim+microfluidic+chips/bio_rxiv__2020__04__28__066746-152-8-11?v=AIM+Biotech
Average 90 stars, based on 1 article reviews
aim microfluidic chips - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
AIM Biotech microfluidic plastic chips and chip holders
Characterization of TC arrest under flow in the MVNs. (a) Schematic diagram of the <t>microfluidic</t> device used to perfuse MVNs under a constant pressure difference Δ p and cells being carried by luminal flow into (A) narrow channels and (B) impacting the endothelium at bifurcations or (C) large vessels (partially realized with Biorender.com). (b) Speed of inert beads carried by luminal flow driven by different pressure differences ( n = 50 beads tracked in 3 devices, average and standard deviation shown) and arrest efficiency of TCs ( n = 4 devices, average and standard deviation shown) as a function of the pressure difference. (c) Confocal image of two arrest mechanisms showing MDA-MB-231 cells within MVNs arrested by (1) physical trapping and (2) adhesion. The scale bar is 200 µm. (d) Bead speed through the MVNs (n as above, the error bars indicate the standard deviation) and vessel diameter as a function of specific GCX component removal (the error bars indicate the standard deviation between the averages of n = 3 devices, 3 regions of interest each). (e) Arrest efficiency of TCs as a function of GCX enzymatic treatment of the MVNs alone, TCs alone, or both MVNs and TCs ( n = 4 devices). (f) Cumulative percentage of TCs either physically trapped in small vessels or adhered to large vessels in the MVNs ( n > 40 cells). Statistical significance assessed for all data portrayed by 138 student’s t-test, p < 0.05 *, p < 0.01 **, p < 0.0001 ****.
Microfluidic Plastic Chips And Chip Holders, supplied by AIM Biotech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/aim+microfluidic+chips/pm37507708-268-4-13?v=AIM+Biotech
Average 90 stars, based on 1 article reviews
microfluidic plastic chips and chip holders - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
AIM Biotech three-channel microfluidic chip
Characterization of TC arrest under flow in the MVNs. (a) Schematic diagram of the <t>microfluidic</t> device used to perfuse MVNs under a constant pressure difference Δ p and cells being carried by luminal flow into (A) narrow channels and (B) impacting the endothelium at bifurcations or (C) large vessels (partially realized with Biorender.com). (b) Speed of inert beads carried by luminal flow driven by different pressure differences ( n = 50 beads tracked in 3 devices, average and standard deviation shown) and arrest efficiency of TCs ( n = 4 devices, average and standard deviation shown) as a function of the pressure difference. (c) Confocal image of two arrest mechanisms showing MDA-MB-231 cells within MVNs arrested by (1) physical trapping and (2) adhesion. The scale bar is 200 µm. (d) Bead speed through the MVNs (n as above, the error bars indicate the standard deviation) and vessel diameter as a function of specific GCX component removal (the error bars indicate the standard deviation between the averages of n = 3 devices, 3 regions of interest each). (e) Arrest efficiency of TCs as a function of GCX enzymatic treatment of the MVNs alone, TCs alone, or both MVNs and TCs ( n = 4 devices). (f) Cumulative percentage of TCs either physically trapped in small vessels or adhered to large vessels in the MVNs ( n > 40 cells). Statistical significance assessed for all data portrayed by 138 student’s t-test, p < 0.05 *, p < 0.01 **, p < 0.0001 ****.
Three Channel Microfluidic Chip, supplied by AIM Biotech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/aim+microfluidic+chips/pm39887579-58-24-28?v=AIM+Biotech
Average 90 stars, based on 1 article reviews
three-channel microfluidic chip - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
AIM Biotech 3ddax-1 microfluidic cell culture chip
Characterization of TC arrest under flow in the MVNs. (a) Schematic diagram of the <t>microfluidic</t> device used to perfuse MVNs under a constant pressure difference Δ p and cells being carried by luminal flow into (A) narrow channels and (B) impacting the endothelium at bifurcations or (C) large vessels (partially realized with Biorender.com). (b) Speed of inert beads carried by luminal flow driven by different pressure differences ( n = 50 beads tracked in 3 devices, average and standard deviation shown) and arrest efficiency of TCs ( n = 4 devices, average and standard deviation shown) as a function of the pressure difference. (c) Confocal image of two arrest mechanisms showing MDA-MB-231 cells within MVNs arrested by (1) physical trapping and (2) adhesion. The scale bar is 200 µm. (d) Bead speed through the MVNs (n as above, the error bars indicate the standard deviation) and vessel diameter as a function of specific GCX component removal (the error bars indicate the standard deviation between the averages of n = 3 devices, 3 regions of interest each). (e) Arrest efficiency of TCs as a function of GCX enzymatic treatment of the MVNs alone, TCs alone, or both MVNs and TCs ( n = 4 devices). (f) Cumulative percentage of TCs either physically trapped in small vessels or adhered to large vessels in the MVNs ( n > 40 cells). Statistical significance assessed for all data portrayed by 138 student’s t-test, p < 0.05 *, p < 0.01 **, p < 0.0001 ****.
3ddax 1 Microfluidic Cell Culture Chip, supplied by AIM Biotech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/aim+microfluidic+chips/10__1158_slash_2326___6066__cir___22___0017-192-13-17?v=AIM+Biotech
Average 90 stars, based on 1 article reviews
3ddax-1 microfluidic cell culture chip - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
AIM Biotech microfluidic plastic chips and holders
Characterization of TC arrest under flow in the MVNs. (a) Schematic diagram of the <t>microfluidic</t> device used to perfuse MVNs under a constant pressure difference Δ p and cells being carried by luminal flow into (A) narrow channels and (B) impacting the endothelium at bifurcations or (C) large vessels (partially realized with Biorender.com). (b) Speed of inert beads carried by luminal flow driven by different pressure differences ( n = 50 beads tracked in 3 devices, average and standard deviation shown) and arrest efficiency of TCs ( n = 4 devices, average and standard deviation shown) as a function of the pressure difference. (c) Confocal image of two arrest mechanisms showing MDA-MB-231 cells within MVNs arrested by (1) physical trapping and (2) adhesion. The scale bar is 200 µm. (d) Bead speed through the MVNs (n as above, the error bars indicate the standard deviation) and vessel diameter as a function of specific GCX component removal (the error bars indicate the standard deviation between the averages of n = 3 devices, 3 regions of interest each). (e) Arrest efficiency of TCs as a function of GCX enzymatic treatment of the MVNs alone, TCs alone, or both MVNs and TCs ( n = 4 devices). (f) Cumulative percentage of TCs either physically trapped in small vessels or adhered to large vessels in the MVNs ( n > 40 cells). Statistical significance assessed for all data portrayed by 138 student’s t-test, p < 0.05 *, p < 0.01 **, p < 0.0001 ****.
Microfluidic Plastic Chips And Holders, supplied by AIM Biotech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/aim+microfluidic+chips/pm31057399-88-32-36?v=AIM+Biotech
Average 90 stars, based on 1 article reviews
microfluidic plastic chips and holders - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
AIM Biotech microfluidic chips and chip holders hol-2
Characterization of TC arrest under flow in the MVNs. (a) Schematic diagram of the <t>microfluidic</t> device used to perfuse MVNs under a constant pressure difference Δ p and cells being carried by luminal flow into (A) narrow channels and (B) impacting the endothelium at bifurcations or (C) large vessels (partially realized with Biorender.com). (b) Speed of inert beads carried by luminal flow driven by different pressure differences ( n = 50 beads tracked in 3 devices, average and standard deviation shown) and arrest efficiency of TCs ( n = 4 devices, average and standard deviation shown) as a function of the pressure difference. (c) Confocal image of two arrest mechanisms showing MDA-MB-231 cells within MVNs arrested by (1) physical trapping and (2) adhesion. The scale bar is 200 µm. (d) Bead speed through the MVNs (n as above, the error bars indicate the standard deviation) and vessel diameter as a function of specific GCX component removal (the error bars indicate the standard deviation between the averages of n = 3 devices, 3 regions of interest each). (e) Arrest efficiency of TCs as a function of GCX enzymatic treatment of the MVNs alone, TCs alone, or both MVNs and TCs ( n = 4 devices). (f) Cumulative percentage of TCs either physically trapped in small vessels or adhered to large vessels in the MVNs ( n > 40 cells). Statistical significance assessed for all data portrayed by 138 student’s t-test, p < 0.05 *, p < 0.01 **, p < 0.0001 ****.
Microfluidic Chips And Chip Holders Hol 2, supplied by AIM Biotech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/aim+microfluidic+chips/pmc09108369-41-2-10?v=AIM+Biotech
Average 90 stars, based on 1 article reviews
microfluidic chips and chip holders hol-2 - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
AIM Biotech microfluidic chips made from cyclin olefin polymer
Characterization of TC arrest under flow in the MVNs. (a) Schematic diagram of the <t>microfluidic</t> device used to perfuse MVNs under a constant pressure difference Δ p and cells being carried by luminal flow into (A) narrow channels and (B) impacting the endothelium at bifurcations or (C) large vessels (partially realized with Biorender.com). (b) Speed of inert beads carried by luminal flow driven by different pressure differences ( n = 50 beads tracked in 3 devices, average and standard deviation shown) and arrest efficiency of TCs ( n = 4 devices, average and standard deviation shown) as a function of the pressure difference. (c) Confocal image of two arrest mechanisms showing MDA-MB-231 cells within MVNs arrested by (1) physical trapping and (2) adhesion. The scale bar is 200 µm. (d) Bead speed through the MVNs (n as above, the error bars indicate the standard deviation) and vessel diameter as a function of specific GCX component removal (the error bars indicate the standard deviation between the averages of n = 3 devices, 3 regions of interest each). (e) Arrest efficiency of TCs as a function of GCX enzymatic treatment of the MVNs alone, TCs alone, or both MVNs and TCs ( n = 4 devices). (f) Cumulative percentage of TCs either physically trapped in small vessels or adhered to large vessels in the MVNs ( n > 40 cells). Statistical significance assessed for all data portrayed by 138 student’s t-test, p < 0.05 *, p < 0.01 **, p < 0.0001 ****.
Microfluidic Chips Made From Cyclin Olefin Polymer, supplied by AIM Biotech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/aim+microfluidic+chips/pm39882574-184-53-67?v=AIM+Biotech
Average 90 stars, based on 1 article reviews
microfluidic chips made from cyclin olefin polymer - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
AIM Biotech 3d vasculature–on–a–chip microfluidic device aim biotech 3d cell culture chips
Characterization of TC arrest under flow in the MVNs. (a) Schematic diagram of the <t>microfluidic</t> device used to perfuse MVNs under a constant pressure difference Δ p and cells being carried by luminal flow into (A) narrow channels and (B) impacting the endothelium at bifurcations or (C) large vessels (partially realized with Biorender.com). (b) Speed of inert beads carried by luminal flow driven by different pressure differences ( n = 50 beads tracked in 3 devices, average and standard deviation shown) and arrest efficiency of TCs ( n = 4 devices, average and standard deviation shown) as a function of the pressure difference. (c) Confocal image of two arrest mechanisms showing MDA-MB-231 cells within MVNs arrested by (1) physical trapping and (2) adhesion. The scale bar is 200 µm. (d) Bead speed through the MVNs (n as above, the error bars indicate the standard deviation) and vessel diameter as a function of specific GCX component removal (the error bars indicate the standard deviation between the averages of n = 3 devices, 3 regions of interest each). (e) Arrest efficiency of TCs as a function of GCX enzymatic treatment of the MVNs alone, TCs alone, or both MVNs and TCs ( n = 4 devices). (f) Cumulative percentage of TCs either physically trapped in small vessels or adhered to large vessels in the MVNs ( n > 40 cells). Statistical significance assessed for all data portrayed by 138 student’s t-test, p < 0.05 *, p < 0.01 **, p < 0.0001 ****.
3d Vasculature–On–A–Chip Microfluidic Device Aim Biotech 3d Cell Culture Chips, supplied by AIM Biotech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/aim+microfluidic+chips/pm39865283-159-3-7?v=AIM+Biotech
Average 90 stars, based on 1 article reviews
3d vasculature–on–a–chip microfluidic device aim biotech 3d cell culture chips - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

Image Search Results


Characterization of TC arrest under flow in the MVNs. (a) Schematic diagram of the microfluidic device used to perfuse MVNs under a constant pressure difference Δ p and cells being carried by luminal flow into (A) narrow channels and (B) impacting the endothelium at bifurcations or (C) large vessels (partially realized with Biorender.com). (b) Speed of inert beads carried by luminal flow driven by different pressure differences ( n = 50 beads tracked in 3 devices, average and standard deviation shown) and arrest efficiency of TCs ( n = 4 devices, average and standard deviation shown) as a function of the pressure difference. (c) Confocal image of two arrest mechanisms showing MDA-MB-231 cells within MVNs arrested by (1) physical trapping and (2) adhesion. The scale bar is 200 µm. (d) Bead speed through the MVNs (n as above, the error bars indicate the standard deviation) and vessel diameter as a function of specific GCX component removal (the error bars indicate the standard deviation between the averages of n = 3 devices, 3 regions of interest each). (e) Arrest efficiency of TCs as a function of GCX enzymatic treatment of the MVNs alone, TCs alone, or both MVNs and TCs ( n = 4 devices). (f) Cumulative percentage of TCs either physically trapped in small vessels or adhered to large vessels in the MVNs ( n > 40 cells). Statistical significance assessed for all data portrayed by 138 student’s t-test, p < 0.05 *, p < 0.01 **, p < 0.0001 ****.

Journal: bioRxiv

Article Title: Glycocalyx-Mediated Vascular Dissemination of Circulating Tumor Cells

doi: 10.1101/2020.04.28.066746

Figure Lengend Snippet: Characterization of TC arrest under flow in the MVNs. (a) Schematic diagram of the microfluidic device used to perfuse MVNs under a constant pressure difference Δ p and cells being carried by luminal flow into (A) narrow channels and (B) impacting the endothelium at bifurcations or (C) large vessels (partially realized with Biorender.com). (b) Speed of inert beads carried by luminal flow driven by different pressure differences ( n = 50 beads tracked in 3 devices, average and standard deviation shown) and arrest efficiency of TCs ( n = 4 devices, average and standard deviation shown) as a function of the pressure difference. (c) Confocal image of two arrest mechanisms showing MDA-MB-231 cells within MVNs arrested by (1) physical trapping and (2) adhesion. The scale bar is 200 µm. (d) Bead speed through the MVNs (n as above, the error bars indicate the standard deviation) and vessel diameter as a function of specific GCX component removal (the error bars indicate the standard deviation between the averages of n = 3 devices, 3 regions of interest each). (e) Arrest efficiency of TCs as a function of GCX enzymatic treatment of the MVNs alone, TCs alone, or both MVNs and TCs ( n = 4 devices). (f) Cumulative percentage of TCs either physically trapped in small vessels or adhered to large vessels in the MVNs ( n > 40 cells). Statistical significance assessed for all data portrayed by 138 student’s t-test, p < 0.05 *, p < 0.01 **, p < 0.0001 ****.

Article Snippet: Extravasation experiments were conducted in MVNs cultured within AIM microfluidic chips (AIM Biotech, gel channel width of 1.3 mm and 250 µm height).

Techniques: Standard Deviation